500 kids with rare bleeding disorder to be tracked in landmark chinese study
NCT ID NCT06107582
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 500 children aged 6-17 diagnosed with immune thrombocytopenia (ITP), a rare autoimmune disease that causes low platelet counts and bleeding. Researchers will collect data on symptoms, treatments, and outcomes over several years to build a model that predicts how the disease will progress. No new treatments are being tested; the goal is to better understand the condition in Chinese children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC IMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chinese Academy of Medical Science and Blood Disease Hospital
RECRUITINGTianjin, 300020, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental injection aims to boost platelets in chronic blood disorder
- New combo therapy aims to boost platelets in immune disorder
- Can a vitamin a drug boost platelets in Hard-to-Treat ITP?
- Real-World study to track Eltrombopag's effectiveness in ITP patients
- New combo aims to boost platelets in stubborn ITP
- New hope for ITP patients: switching drugs after failed treatment